Michael Klowden
Director · NKGen Biotech, Inc.
Individual
- 2024
- Dec 10, 2024
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Michael Klowden. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- CFIC-2015 NV Family Investments, LLC - $7.50M in NKGN purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael Klowden?
Michael Klowden is a corporate insider, tracked as Director of NKGen Biotech, Inc. (NKGN). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Michael Klowden last file a Form 4?
The only primary Form 4 on record is dated 10 December 2024.